
Policy
Potential Inequities in New Medical Technologies
Even if we solve the ethical questions about using breakthrough techniques such as CRISPR, will all patients have equal access?
Eric B. Kmiec, Ph.D., is the director, Gene Editing Institute, Helen F. Graham Cancer Center & Research Institute, ChristianaCare.
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account